These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 38281931

  • 1. Association between thymic hyperplasia and serum calcium level in Graves' disease.
    Zeng J, Li L, Wei D.
    BMC Endocr Disord; 2024 Jan 29; 24(1):15. PubMed ID: 38281931
    [Abstract] [Full Text] [Related]

  • 2. Graves' Disease with Thymic Hyperplasia: The Response of the Thyroid Function, Thyrotropin Receptor Autoantibody, and Thymic Size to Thiamazole Treatment.
    Tsukada D, Iizuka K, Takao K, Liu Y, Kubota S, Okamoto-Kubota S, Sakurai T, Imaizumi T, Sakai M, Kato T, Mizuno M, Hirota T, Suwa T, Horikawa Y, Yamamoto M, Kubota S, Yabe D.
    Intern Med; 2022 Sep 15; 61(18):2753-2757. PubMed ID: 35228417
    [Abstract] [Full Text] [Related]

  • 3. Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
    Popoveniuc G, Sharma M, Devdhar M, Wexler JA, Carroll NM, Wartofsky L, Burman KD.
    Thyroid; 2010 Sep 15; 20(9):1015-8. PubMed ID: 20718680
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
    Tamaki H, Amino N, Iwatani Y, Tachi J, Kimura M, Mitsuda N, Ichihara K, Tanizawa O, Miyai K.
    Clin Endocrinol (Oxf); 1989 May 15; 30(5):493-503. PubMed ID: 2575017
    [Abstract] [Full Text] [Related]

  • 5. Graves' Patient with Thymic Expression of Thyrotropin Receptors and Dynamic Changes in Thymic Hyperplasia Proportional to Graves' Disease Activity.
    Song YS, Won JK, Kim MJ, Lee JH, Kim DW, Chung JK, Park do J, Park YJ.
    Yonsei Med J; 2016 May 15; 57(3):795-8. PubMed ID: 26996584
    [Abstract] [Full Text] [Related]

  • 6. The coexistence of hypercalcemia, osteoporosis and thymic enlargement in graves' disease: a case report.
    Yan D, Xu Y, Li LX.
    BMC Endocr Disord; 2020 Jun 30; 20(1):97. PubMed ID: 32605565
    [Abstract] [Full Text] [Related]

  • 7. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K.
    Thyroid; 2000 Sep 30; 10(9):809-13. PubMed ID: 11041459
    [Abstract] [Full Text] [Related]

  • 8. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N, Kaneko M, Kitazawa M, Uemura Y, Minagawa S, Miyakoshi M, Kaneko K, Kamoi K.
    J Med Case Rep; 2017 Feb 06; 11(1):32. PubMed ID: 28162094
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS, Sirbu AE, Betivoiu MA, Florea S, Barbu CG, Fica SV.
    Endocrine; 2017 Feb 06; 55(2):478-484. PubMed ID: 27819113
    [Abstract] [Full Text] [Related]

  • 11. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
    Khoo DH, Eng PH, Ho SC, Tai ES, Morgenthaler NG, Seah LL, Fong KS, Chee SP, Choo CT, Aw SE.
    Thyroid; 2000 Dec 06; 10(12):1093-100. PubMed ID: 11201855
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Decreased serum level of IL-7 in patients with active Graves' disease.
    Motylewska E, Nieć M, Siejka A, Komorowski J, Ławnicka H, Świętosławski J, Stępień H.
    Cytokine; 2015 Oct 06; 75(2):373-9. PubMed ID: 26113403
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
    Kahaly GJ, Grebe SK, Lupo MA, McDonald N, Sipos JA.
    Am J Med; 2011 Jun 06; 124(6):S2-3. PubMed ID: 21605717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.